| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |